Skip to main content
. Author manuscript; available in PMC: 2023 May 9.
Published in final edited form as: Transl Res. 2022 Oct 17;253:1–7. doi: 10.1016/j.trsl.2022.10.002

Fig6. HLM006474 attenuates TGF-β1-induced fibroblast differentiation.

Fig6.

A. HLF cells were treated with TGF-β1 for 48 hour, and then cells were post-treated with HLM006474 for an additional 24 hour. FN and α-SMA were examined by immunofluorescence saining. B. Immunoblotting analysis of HLM006474-treated TGF-β1-induced lung myofibroblast cells. C. Immunoblotting analysis of HLM006474-treated IPF-LF cells. Immunoblots are representative of three independent experiments. D. IPF-LF cell migration was measured by a cell scratch assay. n=6, * P<0.01, compared to DMSO-treated cells.